Find the Perfect Plan for Your Investment Journey
R
Latest price
52 Week Range
CA$0.01 - CA$0.04
Next Earnings Date
May 28 2025 (Estimate)
Next Earnings Date
May 28 2025 (Est.)
Latest price
Market Cap | CA$12.56M |
EV | CA$12.50M |
Shares Outstanding | 418.56M |
Beta | 2.10 |
Analyst Rating | NOT_AVAILABLE |
Analyst Target Price | - |
P/E 2015E | - |
P/Revenue 2015E | - |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2015E | - |
Net Profit Margin 2015E | - |
ROE 2015E | - |
ROCE 2014 | -127.12% |
DPS 2015E | - |
Payout Ratio 2015E | - |
Div. Yield 2015E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
R
Revive Therapeutics Ltd.
RVV
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Frank, Michael
Employees
2
Website
revivethera.comIPO Date
2013-07-12
Headquarters
The Canadian Venture Building, 82 Richmond Street East, Toronto, Ontario, M5C 1P1, Canada
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved